The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Lilly(Eli) & Co shares valued at $936,550 were sold by Yuffa Ilya on May 14 ’25. At $749.24 per share, Yuffa Ilya sold 1,250 shares. The insider’s holdings dropped to 27,510 shares worth approximately $19.68 million following the completion of this transaction.
Also, Yuffa Ilya purchased 2,500 shares, netting a total of over 1,873,100 in proceeds.
Before that, DONALD ZAKROWSKI had added 2,000 shares to its account. In a trade valued at $1,643,720, the Officer bought Lilly(Eli) & Co shares for $821.86 each.
As published in a research note from HSBC Securities on April 28, 2025, Lilly(Eli) & Co [LLY] has been rated down from a Buy to a Reduce and the price target has been revised to $700 from $1150. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. Earlier on November 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for LLY stock.
Analyzing LLY Stock Performance
During the last five days, there has been a drop of approximately -2.47%. Over the course of the year, Lilly(Eli) & Co shares have dropped approximately -7.36%. Shares of the company reached a 52-week high of $935.63 on 03/03/25 and a 52-week low of $677.09 on 04/07/25.
Support And Resistance Levels for Lilly(Eli) & Co (LLY)
According to the 24-hour chart, there is a support level at 710.44, which, if violated, would cause prices to drop to 705.67. In the upper region, resistance lies at 721.08. The next price resistance is at 726.95. RSI (Relative Strength Index) is 38.72 on the 14-day chart, showing neutral technical sentiment.
